Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Migalastat in Fabry Disease
NCT00214500Phase 2Completed
- Sponsor
- Amicus Therapeutics
- Start
- Jan 2006
- Primary completion
- Jan 2008
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Started Jan 2006; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00214500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214500.